20-22 May 2025
Hamburg, Germany
20-22 May 2025
Hamburg, Germany
Afternoon Session: Evotec | |
13:00 | Depart CCH |
13:30 | Arrive at Evotec |
13:30 - 14:00 | Welcome Coffee Reception |
14:00 - 16:00 | Technology Showcase and Tour |
16:00 | Depart |
Evotec SE
Manfred Eigen Campus
Essener Bogen 7, 22419
Hamburg, Germany
Evotec is a global biotechnology company committed to advancing drug discovery and development together with our partners for medicines that matter.
Gain insight into approaches that lead to the discovery of the next generation of drugs with higher efficiency and probability of success. Learn more about strategies, integrations of state-of-the-art technologies and disease relevant models within Evotec’s workflows that facilitate hit finding and progression towards leads. Attend for the unique opportunity to meet the scientists who contribute to the end-to-end discovery process from disease relevant cellular models like iPSC through sample management, high-throughput biology and in vitro biology.
Specific areas such as high content imaging, CRISPR screening, mass spectrometry-based screening, high-throughput electro-physiology and others will be accessible. Get to know how Evotec applies automation across different functions in a flexible way to enable robust and reliable data generation according to the highest standards suited to feed our AI/ML algorithms and platforms.
Dirk Winkler leads Hit Identification at Evotec. In his current role, Winkler is in charge of Evotec’s global screening strategy and capabilities, covering a wide range of approaches and technologies from traditional target directed Hit ID, structure based, phenotypic but also biophysical and label-free approaches.